• Flumequine in DNA Topoisomerase II Modulation: Assay Design

  2026-08-05

  Explore Flumequine as a DNA topoisomerase II inhibitor through the lens of advanced assay design, integrating cutting-edge in vitro evaluation strategies. This article offers a unique, practical guide for researchers in DNA replication and cancer biology.

• Cy3 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-08-05

  Explore how the Cy3 TSA Fluorescence System Kit empowers high-sensitivity detection of low-abundance biomolecules in cardiovascular pathology. This article uniquely integrates advanced tyramide signal amplification with new mechanistic insights on endothelial-driven cardiotoxicity, offering a fresh perspective for translational researchers.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-08-04

  DiI (DiIC18(3)) enables robust, selective plasma membrane labeling where aqueous or organelle-selective dyes are ineffective. It should not be used in water-based protocols or for exclusive organelle staining, as its performance depends on correct lipid membrane incorporation and solvent compatibility.

• Atropo-Enantioselective Suzuki Coupling for Axially Chiral B

  2026-08-04

  This study pioneers the catalytic asymmetric synthesis of an axially chiral antimitotic biaryl via an atropo-enantioselective Suzuki cross-coupling. The approach enables access to structurally complex analogues of rhazinilam, offering new directions for anticancer research and chiral biaryl synthesis.

• X-Gal in Molecular Cloning: Optimized Workflows and OSN Assa

  2026-08-03

  X-Gal (5-bromo-4-chloro-indolyl-β-D-galactopyranoside) is indispensable for blue-white colony screening and β-galactosidase activity assays, offering high sensitivity and reproducibility. This article explores advanced experimental workflows, troubleshooting strategies, and recent innovations that leverage APExBIO’s high-purity X-Gal for molecular cloning and olfactory sensory neuron research.

• Targeting Pancreatic Fibrosis via MFGE8-ANXA1-SMAD2/3 Modula

  2026-08-03

  This study provides compelling evidence that umbilical cord-derived mesenchymal stem cells (UCMSCs) and their extracellular vesicles (EVs) can attenuate pancreatic fibrosis in chronic pancreatitis by modulating the MFGE8-dependent ANXA1-SMAD2/3 axis. The findings open new avenues for regenerative and nanomedicine-based interventions in pancreatic disease models.

• Fluo-4 AM Calcium Assay Kit: Scaffold Design, Mechanotransdu

  2026-08-02

  Explore how the Fluo-4 AM Calcium Assay Kit advances intracellular calcium detection within engineered scaffolds, enabling precise mechanotransduction studies and robust GPCR inhibitor screening. This comprehensive article links fiber density-driven cell signaling to practical assay optimization, offering new insight beyond standard workflows.

• PreScission Protease (PSP): Precision Tag Cleavage in Cell A

  2026-08-01

  This article delivers an evidence-driven exploration of PreScission Protease (PSP, SKU K1101) for precise fusion tag removal in protein purification workflows. Drawing on scenario-based lab challenges, it details how this HRV 3C protease offers reproducibility, low-temperature activity, and compatibility with cell viability and condensate biology assays. Researchers will find actionable guidance and protocol parameters tailored for advanced molecular biology applications.

• Alternariol (AOH): Unraveling Hepatotoxic Mechanisms and Ass

  2026-07-31

  Explore the multifaceted role of Alternariol (AOH) in mycotoxin research, with a deep dive into its hepatotoxic mechanisms and assay optimization. This article provides unique insights for researchers seeking rigorous, actionable protocols and a scientific edge.

• iRhom2 Regulates Odorant Receptor Adaptation in Olfactory Ne

  2026-07-31

  Azzopardi et al. uncover iRhom2 as a key modulator of olfactory receptor gene regulation and neuronal adaptation in mice, linking iRhom2/ADAM17 signaling to activity-dependent feedback in olfactory sensory neurons. These findings refine our understanding of sensory gene regulation and offer new molecular entry points for studying GPCR-driven adaptation.

• Sphingosine-1-phosphate: Applied Workflows in Cell Survival

  2026-07-30

  Harness Sphingosine-1-phosphate (S1P) for precision modulation of cell proliferation, apoptosis, and vascular maturation in advanced research models. This guide delivers stepwise protocol enhancements, troubleshooting strategies, and insight into the latest mechanistic breakthroughs, anchored by APExBIO’s rigorously validated S1P and the newest reference data on apoptosis signaling.

• Bromodomain Inhibitor, (+)-JQ1: Applied Workflows & Optimiza

  2026-07-30

  Bromodomain Inhibitor, (+)-JQ1 unlocks precise BET bromodomain targeting for apoptosis, inflammation modulation, and emerging non-hormonal male contraception applications. This guide distills the latest experimental workflows, troubleshooting strategies, and translational insights to maximize impact across cancer, stem cell, and immunology research.

• SIRT1/2 Inhibitor IV (cambinol): Translational Research Work

  2026-07-29

  SIRT1/2 Inhibitor IV (cambinol) empowers bench scientists to dissect SIRT1- and SIRT2-regulated processes in cancer and CNS injury. This guide details experimental workflows, optimization strategies, and troubleshooting tips, with a special focus on astrocyte polarization, tumor models, and advanced acetylation assays.

• Cy3 TSA Fluorescence System Kit: Pushing Sensitivity in IHC

  2026-07-29

  The Cy3 TSA Fluorescence System Kit empowers researchers to visualize low-abundance biomolecules with unprecedented clarity in immunohistochemistry, immunocytochemistry, and in situ hybridization. Leverage advanced tyramide signal amplification to unlock new levels of sensitivity for protein and nucleic acid detection, as demonstrated in translational cancer research.

• Galectin-1 Suppresses Hepatic Autophagy via FIP200 in NAFLD

  2026-07-28

  This study uncovers galectin-1 as a direct suppressor of hepatic autophagy through its interaction with the scaffold protein FIP200, elucidating a novel molecular mechanism underlying the progression of non-alcoholic fatty liver disease (NAFLD). The findings reveal a specific interface mediating Gal-1’s inhibitory effect and suggest new intervention points for metabolic liver diseases.

15176 records 1/1012 page Next 12345 下5页 Last page